
XNK Therapeutics AB raises €12.75m
XNK Therapeutics said it will use the proceeds to accelerate an investigator-initiateed open Phase II study with its autologous NK cell-based...

Evotec signs contracts with Almirall and Sernova
Under the alliance Evotec is set to discover novel targets or therapeutics for skin diseases such as atopic dermatitis or basal cell carcinoma....

Scenic Biotech BV announces $31m financing
The round was co-led by seasoned European investors, Eir Ventures, a Nordic Life Science venture fund, Switzerland-based BioMedPartners and...

Syndesi swallowed by Abbvie
Originally, Belgian Syndesi was created in 2017 through a partnership between UCB Biopharma SRL and a syndicate of Belgian and international...

Argenx SE to raise €637m
Last December, the Breda-based drugmaker got the green lightfrom the US FDA for its injectible anti-acetylcholin receptor antibody fragment...

Switzerland paves the way for genome editing
Following in the footsteps of the UK, Switzerland wants to exempt genome editing and targeted mutagenesis in plant breeding from the Swiss Genetic...

Join 900 US CEOs protest against Ukraine invasion
As Russia continues its unprovoked war on Ukraine, the U.S. life sciences community is united in its total rejection of the criminal actions taken by...